Home/Recalls/CANADA-54282
Health CanadaGeneral Alert

BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to R...

Published: October 23, 2015Recall ID: 54282Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect

Additional Source Details

FieldValue
N I D54282
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/bravelle-75-iu-urofollitropin-injection-purified-recalled-lots-due-reduced-therapeutic
IssueProduct safety
Title BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect
Archived1
CategoryDrugs
Last updated2015-10-23
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert